Author Question: A synarthrosis is a type of joint that: A) permits only slight movement. B) allows movement. C) ... (Read 178 times)

burton19126

  • Hero Member
  • *****
  • Posts: 532
A synarthrosis is a type of joint that:
 
  A) permits only slight movement.
  B) allows movement.
  C) does not permit movement.
  D) allows free movement.

Question 2

A rounded projection that enters into the formation of a joint is a:
 
  A) fossa.
  B) trochanter.
  C) sinus.
  D) condyle.



leannegxo

  • Sr. Member
  • ****
  • Posts: 374
Answer to Question 1

C
Explanation: A) An amphiarthrosis permits very slight movement.
B) An amphiarthrosis and a diarthrosis allow movement.
C) Correct.
D) A diarthrosis permits free movement in a variety of directions.

Answer to Question 2

D
Explanation: A) A fossa is a shallow depression in or on a bone.
B) A trochanter is a bony projection below the neck of the femur.
C) A sinus is an air cavity in a bone.
D) Correct.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Common abbreviations that cause medication errors include U (unit), mg (milligram), QD (every day), SC (subcutaneous), TIW (three times per week), D/C (discharge or discontinue), HS (at bedtime or "hours of sleep"), cc (cubic centimeters), and AU (each ear).

Did you know?

Oliver Wendell Holmes is credited with introducing the words "anesthesia" and "anesthetic" into the English language in 1846.

Did you know?

Malaria was not eliminated in the United States until 1951. The term eliminated means that no new cases arise in a country for 3 years.

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates's recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library